Search results - 5 results
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Publication Type: Peer reviewed scientific article Authors: Bhatia, Ramya; Alcaniz Boada, Elia; Bonde, Jesper Hansen; Quint, Wim G V; Xu, Lan; Ejegod, Ditte Moller; Cuschieri, Kate; M. Arbyn Source: ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Cuschieri, Kate; M. Arbyn Source: J Med Virol, Volume 95, Issue 1 (2023) Keywords: Early Detection of Cancer Female Genotyping Techniques Human Papillomavirus Viruses Humans Papillomaviridae Papillomavirus ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; E Peeters; I Benoy; D Vanden Broeck; J Bogers; P De Sutter; G Donders; W Tjalma; S Weyers; Cuschieri, K; Poljak, M; J Bonde; ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Publication Type: Peer reviewed scientific article Authors: Geraets, D T; Cuschieri, K; de Koning, M N C; van Doorn, L J; Snijders, P J F; Meijer, C J L M; Quint, W G V; M. Arbyn Source: J Clin ...
Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; P. Rousta; Sharon Dhillon; M. Gultekin; K. Cuschieri Source: ESGO Textbook of Gynaecological Oncology, Number 120 (2023) ...